Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Histogenics Corporation

NASDAQ: HSGXHealthcare / Biotechnology / USA
0.130000.00Vol 4 394 7391Y Perf -94.89%
Feb 20th, 2019 16:00
BID0.1300 ASK0.1300
Open0.1300 Previous Close0.1300
Pre-Market- After-Trading-
 - -%  - -%
Target Price
1.50 
Analyst Rating
Hold 3.00
Potencial %
1 053.85 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/33/40 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-95 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-100/39/39 
Income Ranking
 —    -
Market Cap (mil)8 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
1.53 
Earnings Date
21st Mar 2019

Today's Price Range

0.13000.1400

 

52wk Range

0.08003.35

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Month
-18.75%
3 Months
-75.93%
6 Months
-94.72%
1 Year
-94.89%
3 Years
-95.00%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
HSGX0.13000.00000.00
AAPL172.031.10000.64
GOOG1 113.80-4.7600-0.43
MSFT107.15-1.0200-0.94
XOM78.530.30000.38
WFC49.810.43000.87
JNJ136.350.66000.49
FB162.560.27000.17
GE10.10-0.0300-0.30
JPM105.690.51000.48
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.60
Current Ratio
0.70
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio -0.90
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
60.23
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-0.80
Cash Flow Per Share
-0.47
Price to Tangible Book
-0.84
Book Value per Share
-0.16
Enterprise Value (in ths.)
2 933
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-669.65
ROE last 12 Months
190.81
Return on Assets (5Y Avg)
-194.09
ROA last 12 Months
-103.78
Return on Capital (5Y Avg)
-604.77
ROC last 12 Months
-
Return on invested Capital Q
-
Return on invested Capital Y
-1 470.52
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.19-0.24-26.32
Q02 2018-0.22-0.25-13.64
Q01 2018-0.07-0.20-185.71
Q04 2017-0.31-0.2616.13
Q03 2017-0.30-0.2323.33
Q02 2017-0.31-0.2519.35
Q01 2017-0.48-0.2645.83
Q04 2016-0.47-1.60-240.43
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.0660.00Positive
12/2018 FY-0.0491.30Positive
3/2019 QR-0.0195.45Positive
12/2019 FY-0.03--
Next Report Date21st Mar 2019
Estimated EPS Next Report-0.06
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume4 394 739
Shares Outstanding (in ths.)62 025
Trades Count3 625
Dollar Volume577 770
Avg. Volume11 922 976
Avg. Weekly Volume4 531 696
Avg. Monthly Volume8 628 659
Avg. Quarterly Volume8 797 173

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
1 (33.33 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (100.00 %)
2 (66.67 %)
1 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Moderate Buy
2.33
Strong Buy
1.50

There are no comments yet.

News